Distinct blood and visceral adipose tissue regulatory T cell and innate lymphocyte profiles characterize obesity and colorectal cancer by Donninelli, Gloria et al.
June 2017 | Volume 8 | Article 6431
Original research
published: 09 June 2017
doi: 10.3389/fimmu.2017.00643
Frontiers in Immunology | www.frontiersin.org
Edited by: 
Jixin Zhong, 
Case Western Reserve University, 
United States
Reviewed by: 
Fei Teng, 
Weill Cornell Medical College, 
United States  
Rui Mao, 
Augusta University, 
United States  
Xun Liu, 
Brigham and Women’s Hospital, 
United States
*Correspondence:
Lucia Conti 
lucia.conti@iss.it
†These authors have contributed 
equally to this work.
Specialty section: 
This article was submitted 
to Inflammation, 
a section of the journal 
Frontiers in Immunology
Received: 04 April 2017
Accepted: 17 May 2017
Published: 09 June 2017
Citation: 
Donninelli G, Del Cornò M, 
Pierdominici M, Scazzocchio B, 
Varì R, Varano B, Pacella I, 
Piconese S, Barnaba V, D’Archivio M, 
Masella R, Conti L and Gessani S 
(2017) Distinct Blood and Visceral 
Adipose Tissue Regulatory T Cell and 
Innate Lymphocyte Profiles 
Characterize Obesity and Colorectal 
Cancer. 
Front. Immunol. 8:643. 
doi: 10.3389/fimmu.2017.00643
Distinct Blood and Visceral adipose 
Tissue regulatory T cell and innate 
lymphocyte Profiles characterize 
Obesity and colorectal cancer
Gloria Donninelli 1†, Manuela Del Cornò1†, Marina Pierdominici1, Beatrice Scazzocchio1, 
Rosaria Varì1, Barbara Varano1, Ilenia Pacella2, Silvia Piconese2,3, Vincenzo Barnaba2,3, 
Massimo D’Archivio1, Roberta Masella1, Lucia Conti1* and Sandra Gessani 1
1 Center for Gender-Specific Medicine, Istituto Superiore di Sanità, Rome, Italy, 2 Dipartimento di Medicina Interna e Specialità 
Mediche, Sapienza Università di Roma, Rome, Italy, 3 Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Rome, Italy
Visceral adipose tissue (VAT) is a main site where metabolic and immunologic processes 
interplay to regulate, at local and systemic level, the inflammatory status and immune 
response. Obesity-associated inflammation and immune dysfunctions are inextricably 
linked to tumor but, in spite of intense efforts, the mechanisms underpinning this asso-
ciation remain elusive. In this report, we characterized the profile of VAT-associated and 
circulating innate lymphocyte and regulatory T (Treg) cell subsets underlying inflammatory 
conditions, such as obesity and colorectal cancer (CRC). Analysis of NK, NKT-like, γδ T, 
and Treg cell populations in VAT and blood of healthy lean subjects revealed that CD56hi 
NK and OX40+ Treg cells are more abundant in VAT with respect to blood. Conversely, 
CD56dim NK and total Treg cells are most present in the circulation, while γδ T lymphocytes 
are uniformly distributed in the two compartments. Interestingly, a reduced frequency 
of circulating activated Treg cells, and a concomitant preferential enrichment of OX40-
expressing Treg cells in VAT, were selectively observed in obese (Ob) subjects, and 
directly correlated with body mass index. Likewise, CRC patients were characterized by 
a specific enrichment of VAT-associated NKT-like cells. In addition, Ob and CRC-affected 
individuals shared a significant reduction of the Vγ9Vδ2/γδ T cell ratio at systemic level. 
The alterations in the relative proportions of Treg and NKT-like cells in VAT were found 
to correlate with the content of pro- and anti-inflammatory polyunsaturated fatty acids 
(PUFA), respectively. Overall, these results provide evidence for distinct alterations of the 
immune cell repertoire in the periphery with respect to the VAT microenvironment that 
uniquely characterize or are shared by different inflammatory conditions, such as obesity 
and CRC, and suggest that VAT PUFA composition may represent one of the factors that 
contribute to shape the immune phenotypes.
Keywords: adipose tissue, fatty acid, obesity, colorectal cancer, immune profile, regulatory T cell, γδ T lymphocyte, 
nKT-like cell
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inTrODUcTiOn
Obesity has become a major threat to public health because of 
its high global prevalence and association with an increased risk 
of developing chronic diseases. Obesity affects over half a billion 
adults worldwide, with ~3.5 million attributable deaths each year 
(1). Similar to gender, race, dietary habits, or smoking history, 
obesity is one of the risk factors for several types of cancer includ-
ing colorectal cancer (CRC) (2, 3) and contributes to 3–20% of 
cancer deaths in western populations (4, 5). CRC is one of the 
most common gastrointestinal malignant tumors in the world 
and presents one of the highest rates of morbidity and mortality 
worldwide (6). Abdominal rather than total adiposity is associ-
ated with a 1.5- to 3.5-fold increased risk of developing CRC as 
compared to lean individuals (7).
Obesity-associated low-grade chronic inflammation is consid-
ered a main risk factor for adiposity-related pathologies including 
CRC (8). Indeed, a well-established link between CRC and chronic 
inflammation, sustained by tumor cell-extrinsic as well as -intrinsic 
pathways, has been recognized in multiple settings. It is generally 
accepted that visceral adipose tissue (VAT)-resident immune cells 
play a major role in the obesity-associated inflammatory status. 
Notably, dietary components are recognized as important modu-
lators of inflammation, and healthy/unhealthy diets have been 
associated with reduced/increased CRC prevalence, respectively 
(9). Emerging key players in the processes leading to immune sur-
veillance failure that may favor cancer onset in obese (Ob) subjects 
are the VAT and its composition in fatty acids (FA), in particular 
the pro-inflammatory polyunsaturated fatty acids (PUFA) (10, 11). 
Interestingly, dietary intake has been directly linked to PUFA 
composition of VAT (12) and CRC cell growth as well as tumor 
progression in mouse models (13). Thus, VAT might represent the 
initial place where PUFA-related dietary information is transferred 
to the immune system and contributes to regulate homeostasis.
VAT is immunologically dynamic and contains many different 
cell types including adipocytes and their progenitors, endothelial 
cells, and immune cells (14). Recent studies showed clearly that 
the balance between homeostasis and inflammation in adipose 
tissue (AT) is mainly controlled by the stromal vascular fraction 
(SVF) that contains, in homeostatic conditions, a unique reper-
toire of immune cells (15, 16), whose numbers and activation 
level have been reported to be altered in obesity. AT homes cells 
with both pro-inflammatory [M1 macrophages, neutrophils, 
Th1 CD4+ T cells, CD8+ T cells, B cells, dendritic cells (DC), and 
mast cells] and anti-inflammatory [M2 macrophages, regulatory 
T (Treg) cells, Th2 CD4+ T  cells, eosinophils, and type 2 innate 
lymphoid cells, ILC2] activity. Among them, Treg cells are a 
CD4+ T  cell subset specialized in immune suppression, and in 
maintaining immune system homeostasis (17). Furthermore, 
innate lymphocytes have been also recently reported to populate 
AT (18). In particular, NKT  cells, a lineage of T  lymphocytes 
exhibiting NK cell features (19), play beneficial or harmful roles 
in obesity-associated inflammation and comorbidities (20) as 
well as in CRC development/progression (21, 22). In addition, 
NK and γδ T cells are key players in immune surveillance against 
cancer, and impairment of their function and frequency has been 
observed in chronic inflammatory conditions (23, 24). Finally, 
recent studies have highlighted the regulatory role of ILC2 in 
AT metabolism and homeostasis (16). Thus, AT homeostasis is 
maintained through the regulation of the immune cell profile, 
and obesity skews this balance toward a pro-inflammatory status. 
The tumor-promoting effects of obesity occur not only at local 
level, via altered VAT microenvironment, but also systemically, 
via dysregulated immune cell profile and circulating inflamma-
tory factors that mirror adipose inflammation. However, the 
alterations in immune cell repertoires occurring in the peripheral 
blood (PB), VAT, and proximal tissues deserve further investiga-
tion in order to elucidate the extent of immune dysregulation in 
obesity that may set the basis for cancer development.
In this study, we investigated the profile of human VAT-associated 
and systemic γδ T, NK, NKT-like, and Treg cells in lean and obese 
(Ob) subjects, affected or not by CRC. We report that in healthy lean 
subjects innate lymphocyte subsets and Treg cells exhibit a differential 
distribution in blood with respect to VAT. Furthermore, we identify 
alterations of the immune cell profile specific for Ob subjects, such 
as a reduced level of circulating activated Treg (aTreg) cells paralleling 
a preferential enrichment of OX40-expressing Treg cells in VAT, or 
for CRC patients, such as an increased VAT-associated NKT-like 
cell frequency. In addition, obesity and CRC share a significant 
reduction of the Vγ9Vδ2/γδ T cell ratio at systemic level. Of note, 
the alterations in the relative proportions of Treg and NKT-like cells 
in VAT correlate with the its content of pro- and anti-inflammatory 
PUFA, respectively, in both pathological conditions.
Overall, these results provide evidence for distinct alterations 
of the immune cell repertoire in the periphery with respect to the 
VAT microenvironment that uniquely characterize, or are shared 
by, obesity and CRC, and suggest a role for VAT PUFA composi-
tion in shaping immune phenotypes.
MaTerials anD MeThODs
Patients and samples
Human VAT biopsies and blood samples from the same individual 
were collected from lean and Ob subjects undergoing abdominal 
surgery or laparoscopy for benign (i.e., gallbladder disease 
without icterus, umbilical hernia, and uterine fibromatosis) or 
CRC conditions (histologically proved primary colon adenocar-
cinoma, stage TNM 0–III). The exclusion criteria were as follows: 
clinical evidence of active infection, recent (within 14 days) use 
of antibiotics/anti-inflammatory drugs, pregnancy, hormonal 
therapies, severe mental illness, autoimmune diseases, family 
history of cancer, other neoplastic diseases. Subjects belonging 
to four groups were enrolled: normal weight (Nw), Ob, Nw with 
CRC (Nw/CC), and Ob with CRC (Ob/CC). In the Nw groups, 
the body mass index (BMI) range was 18–24.9 kg/m2. In the Ob 
groups, BMI was ≥30 kg/m2, and waist circumference ≥95 cm 
for men and ≥80 cm for women. For each category, the number 
of subjects ranged from a minimum of 6 to 16 for Nw, 4 to 15 for 
Ob, 6 to 13 for Nw/CC, 6 to 10 for Ob/CC. The different quantity 
of biological samples available for each single donor did not allow 
to perform all the analyses on the same number of subjects.
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Blood samples were drawn at the time of obtaining peripheral 
vein access for surgery. Peripheral blood mononuclear cells were 
separated by Ficoll-Hypaque density-gradient centrifugation and 
collected in complete RPMI 1640 medium containing 10% FBS, 
2  mM l-glutamine, penicillin/streptomycin (Euroclone). VAT 
biopsies were microdissected, rinsed several times in 0.9% NaCl, 
and digested with 5 ml of Krebs-Ringer solution (0.12 M NaCl, 
4.7  M KCl, 2.5  mM CaCl2, 1.2  mM MgSO4, 1.2  mM KH2PO4) 
containing 20  mM HEPES pH 7.4, 3.5% fatty acid-free BSA, 
200 nM adenosine, 2 mM glucose, and type 1 collagenase for 1 h 
(1  mg/g tissue) at 37°C in shaking water bath. VAT SVF were 
obtained as previously described (25). Briefly, 15–40  g of VAT 
biopsies were microdissected and extensively washed with sterile 
PBS to remove contaminating erythrocytes. The extracellular 
matrix was digested with 0.1% type I collagenase at 37°C, and 
shaken vigorously for 60 min in shaking water bath to separate 
the stromal cells from primary adipocytes. Dissociated tissue 
was filtered to remove debris, and centrifuged at 1,500 rpm for 
10  min. The suspending portion containing lipid droplets was 
discarded and the cell pellet was resuspended, washed twice, and 
cultured in complete RPMI 1640.
Flow cytometry
Peripheral blood mononuclear cells and VAT SVF cells were 
stained with fluorochrome-labeled antibodies CD3 (FITC), CD4 
(FITC or BrilliantViolet 785), CD45RA (APC or BrilliantViolet 
605), CD127 (PeCy7), γδ TCR (PE), Vδ2 (FITC), CD56 
(BrillantViolet 421), OX40 (PE), CD16 (APC). Intracellular 
staining for FOXP3 was performed using the anti-FOXP3 (PE 
or PerCP-Cy5.5) mAb and FOXP3 Transcription Factor Staining 
Buffer Set according to manufacturer’s instructions (eBiosci-
ence). At first, cells were incubated 30 min at room temperature 
(RT) with Fixable Viability Dye (eFluor 780, eBioscience) to stain 
and exclude dead cells, then staining with antibodies for surface 
antigens was performed for 20 min at 4°C. FOXP3 intracellular 
staining was performed incubating cells for 30 min at RT. Data 
were acquired on LSR Fortessa (Becton Dickinson) and analyzed 
with FlowJo software (Tree Star Inc., version 10.1r5) or on 
FACSCalibur flow Cytometer (BD Biosciences) and analyzed 
with the Cell Quest Pro software.
Fa analysis
Total lipids from VAT samples were extracted with chloroform–
methanol 2:1 (v/v) and FA methyl esters prepared (26) and 
analyzed as previously described (10). The individual FA detected 
were expressed as a percent of total FA.
statistical analysis
GraphPad Prism 5 software was used for statistical analysis. 
Statistical comparison between groups was performed by the 
one-way analysis of variance with Newman–Keuls post hoc test 
and by the two-tailed unpaired Student’s t-test for independent 
samples, as appropriate. Comparisons were expressed as means 
from several experiments ± SEM. Pearson’s test was performed to 
determine simple correlations between two variables. Differences 
were considered significant when p values were <0.05.
resUlTs
human innate lymphocytes and Treg cells 
are Differentially Distributed in PB and 
VaT in healthy subjects
Several immune cell subsets populate the AT, and alterations of their 
relative numbers and functions have been suggested to influence 
obesity-associated local and systemic inflammation as well as CRC 
development/progression. We initially quantified the frequency of 
innate lymphocyte populations (γδ T, NK, NKT-like cells) and Treg 
cells in homeostatic conditions assessing matched VAT SVF and 
PB samples collected from healthy lean subjects. The gating strate-
gies and representative plots for each cell population are reported 
in Figures  1A,F and Figure S1 in Supplementary Material. As 
shown in Figure 1, no significant differences were observed in the 
tissue distribution of total γδ T lymphocytes (Figure 1B). However, 
the analysis of other innate cell populations revealed a preferential 
accumulation of the CD56hi NK cell subset in VAT SVF as compared 
to PB (Figure 1D), whereas the majority of circulating NK cells was 
CD56dim (Figure 1E). In keeping with previously published data 
highlighting that NKT cells are one of the AT resident cell subsets, 
a general enrichment of the CD3+CD56+ NKT-like cell population 
was found in VAT SVF (Figure 1C) as compared to PB. Concomitant 
with the accumulation of NKT-like cells, a significant decrease of 
Treg cell (CD4+FOXP3+CD127low) frequency was observed at local 
level as compared to PB (Figure 1G). Recently, different Treg cell 
subpopulations have been described, such as aTreg cells which have 
suppressive function, resting Treg (rTreg) cells which can convert 
to aTreg, and non-suppressive Treg (nsTreg) cells (27). Moreover, the 
OX40-expressing Treg, cell subset, with strong suppressive activity 
and high proliferative potential, has been described to be associated 
with tissue localization and especially cancer microenvironments 
(28, 29). Of note, when these cell subsets were characterized, an 
opposite tissue distribution was observed between aTreg and OX40-
expressing Treg cells (Figures  1H,I). Specifically, a significantly 
higher frequency of aTreg cells was detected at systemic with respect 
to local level (Figure 1H). Conversely, OX40-expressing cells were 
found selectively distributed in VAT SVF (Figure 1I), in line with 
the role of OX40 in imparting preferential survival to Treg cells in 
tissues.
Obesity is associated with a reduced 
Frequency of circulating aTreg cells  
and a Preferential enrichment of OX40-
expressing Treg cells in VaT
In chronic inflammatory diseases, such as obesity and cancer, the 
effector/regulatory equilibrium may be persistently perturbed, 
finally contributing to tumor progression by suppressing anti-
tumor immunity (30). Therefore, we compared the frequency 
of Treg cells in PB of lean and Ob subjects, affected or not by 
CRC. Anthropometric and clinical parameters of study subjects 
are shown in Table 1. Although no changes in the frequency of 
total Treg cells were observed among the four donor categories 
studied (Figure 2A), a deeper analysis of Treg cell subsets revealed 
a significantly reduced frequency of circulating aTreg cells in Ob 
TaBle 1 | Anthropometric and clinical parameters of study subjects.
subjects nw Ob nw/cc Ob/cc
Number (54) 16 15 13 10
Body mass 
index (kg/m2)
23.9 ± 0.78 41.22 ± 8.58 22.50 ± 1.93 32.79 ± 2.17
Age (years) 46.07 ± 12.83 32.83 ± 11.02 61.08 ± 12.85 65 ± 10.3
Sex (female/
male)
8/8 7/8 9/4 3/7
Stage 0 – – 1 1
Stage I – – 5 3
Stage II – – 3 3
Stage III – – 4 3
FigUre 1 | Composition of major T lymphocyte subpopulations in visceral adipose tissue (VAT) stromal vascular fraction (SVF) versus peripheral blood (PB) of lean 
healthy subjects. Cell subset percentages within total PB and VAT SVF lymphocytes of nine healthy lean subjects were analyzed. Gating strategies for NK, NKT,  
T, and γδ T cells (a), total regulatory T (Treg), conventional T cells (Tconv), OX40+ Treg and activated Treg cells (aTreg) (F), in PB and SVF from a representative donor. γδ 
T cells, TCRγδ+CD3+ (B); NK cells, CD3−CD56+ (D,e); NKT cells, CD3+CD56+ (c); Treg cells, CD4+FOXP3+CD127low (g); aTreg, FOXP3highCD45RA− (h); OX40+ Treg 
cells (i). Each dot represents an individual donor. Mean ± SEM is shown for each group. *p < 0.05, **p < 0.01, by unpaired Student’s t-test.
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individuals, independent of CRC (Figure 2B). Notably, correla-
tion analysis showed that the frequency of this subpopulation 
inversely correlates with BMI (Figure 2C). The percentage of rTreg 
and nsTreg cell subsets was not affected by obesity or CRC (Figure 
S2 in Supplementary Material).
The analysis of Treg cells at the tissue level revealed that these 
cells accumulate in VAT SVF of Ob individuals, but not of CRC-
affected subjects (Figure 3A), and that their frequency positively 
correlates with BMI (Figure  3B). Based on the pivotal role of 
OX40 in supporting Treg cell fitness (28, 31) and on its selective 
expression in VAT-associated Treg cells in healthy lean subjects 
(Figure  1I), we investigated whether the accumulation of this 
cell population observed in VAT SVF of Ob individuals was 
associated with a higher expression of OX40. Indeed, we found 
that the frequency of OX40-expressing Treg cells was significantly 
higher in Ob subjects with respect to all other categories of 
individuals (Figure 3C). Conversely, the frequency of aTreg cells 
remained unchanged (Figure  3D). Interestingly, the extent of 
OX40 expression in Treg cells showed a positive correlation with 
BMI (Figure  3E). As shown in Figure S3 in Supplementary 
FigUre 2 | A significant reduction of circulating CD45RA−FOXP3hi activated 
Treg (aTreg) cells occurs in obese (Ob) subjects: correlation with body mass 
index (BMI). Peripheral blood (PB) lymphocytes isolated from lean normal 
weight (Nw), Ob, lean affected by colorectal cancer (CRC) (Nw/CC), and Ob 
affected by CRC (Ob/CC) donors were analyzed by flow cytometry. 
Frequency of regulatory T (Treg) (CD4+FOXP3+CD127low) cells (a) and aTreg 
cells (CD4+FOXP3high CD45RA−) (B) was estimated in PB of the four groups. 
Each dot represents an individual donor. Mean ± SEM is shown for each 
group. *p < 0.05 by analysis of variance. (c) Pearson’s correlation (r) 
between aTreg cell frequency and BMI in all subjects (**p < 0.01).
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the frequency of OX40+ Tconv cells did not correlate with BMI 
(Figure S3B in Supplementary Material). These data suggest that, 
in the VAT microenvironment, obesity prompts Treg cell expan-
sion, possibly as a negative feedback mechanism to counteract 
inflammation. Notably, this event seems disrupted in VAT of 
CRC patients, despite obesity.
a selective enrichment of VaT-associated 
nKT-like cells characterizes crc 
condition
To investigate whether the frequency of NK and NKT-like cells at 
systemic and VAT level could be affected by obesity and/or CRC, 
flow cytometric analysis of these subsets was also performed in 
the four categories of subjects. As shown in Figure  4A, CRC 
condition, rather than obesity, is characterized by an enrichment 
of CD3+CD56+ NKT-like cells. Specifically, a higher frequency of 
this cell population was detected in VAT SVF from CRC-affected 
subjects as compared to cancer-free individuals, irrespective 
of their BMI. Conversely, no changes in the frequency of total 
NK cells were observed in VAT SVF and PB among all categories 
of subjects (Figure 4B). Moreover, the tissue distribution of the 
CD56hi and CD56low NK cell subsets was not affected by obesity 
or CRC (data not shown).
Obesity and crc share a reduced 
Vγ9Vδ2/γδ T cell ratio at systemic level
Among γδ T lymphocytes, the main circulating subset Vγ9Vδ2 has 
been involved in immunosurveillance against cancer, and impair-
ment of its function and frequency has been observed in chronic 
inflammatory conditions (24). We thus investigated the distribu-
tion of γδ T cells and of the Vγ9Vδ2 subset, in PB with respect 
to VAT, in the four categories of subjects. Although no significant 
differences were observed in the frequency of VAT-associated 
(Figure 5A) and PB (Figure 5B) total γδ T lymphocytes (Figure 5), 
when the analysis was extended to the Vγ9Vδ2 subset, a significant 
reduction of the Vγ9Vδ2/γδ T cell ratio was found in the systemic 
compartment of Ob and CRC-affected subjects as compared to 
healthy lean individuals (Figure 5C). Of note, an inverse correla-
tion was observed between the Vγ9Vδ2/γδ T cell ratio and BMI 
when Ob and lean subjects were considered (Figure 5D).
Treg and nKT-like cells are inversely 
Distributed in VaT and Their Frequencies 
correlate with individual PUFa content
An interplay between NKT and Treg cells has been described in 
different settings. In particular, NKT  cells can promote Treg cell 
induction and, conversely, Treg cells can exhibit suppressive activity 
on NKT cells (32, 33). Based on this knowledge and on our obser-
vation that these immune cell subsets are differently distributed 
in VAT SVF from Ob and CRC subjects (Figures 3A and 4A), a 
correlation analysis between the frequencies of total Treg and NKT-
like cells was performed to assess the influence of obesity and 
CRC conditions on this relationship in human VAT. Interestingly, 
as shown in Figure  6A, we observed a significant inverse cor-
relation between these cell populations, indicative of a potential 
negative interplay. This inverse relation may explain the alternate 
Material, an increased expression of OX40 was also found in 
VAT-associated CD4+FOXP3− conventional T  cells (Tconv) from 
Ob subjects (Figure S3A in Supplementary Material); however, 
FigUre 3 | A significant increase of total regulatory T (Treg) cells and a preferential enrichment of OX40+ Treg cells occur in visceral adipose tissue (VAT) stromal 
vascular fraction (SVF) from obese (Ob) subjects: correlation with body mass index (BMI). VAT SVF lymphocytes isolated from lean normal weight (Nw), Ob, lean 
affected by colorectal cancer (CRC) (Nw/CC), and Ob affected by CRC (Ob/CC) donors were analyzed by flow cytometry. Frequencies of Treg (CD4+FOXP3+CD127low) 
cells (a), OX40+ Treg cells (c), and activated Treg cells (CD4+FOXP3highCD45RA−) (D) were estimated in VAT SVF of the four donor groups. Each dot represents an 
individual donor. Mean ± SEM is shown for each group. *p < 0.05, **p < 0.01 by analysis of variance. Pearson’s correlation (r) between Treg (B) or OX40+ Treg  
(e) cell frequencies and BMI, in all subjects (*p < 0.05).
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prevalence of NKT-like cells in VAT of CRC-affected patients, and 
of Treg cells in VAT of CRC-free Ob subjects (Figures 3A and 4A).
We have previously demonstrated a significant decrease in the 
ω3/ω6 PUFA ratio in Ob and CRC-affected subjects with respect 
to healthy lean individuals (10). Therefore, we investigated whether 
obesity- or cancer-associated modulation of specific immune cell 
subsets could be somehow related to distinct PUFA profiles, focus-
ing on individual ω3 and ω6 PUFA. Correlation analysis showed 
that the Treg cell frequency in VAT SVF positively correlates with ω6 
PUFA arachidonic acid (AA) content when lean and Ob subjects 
were considered (Figure  6B). Likewise, the frequency of VAT-
associated NKT-like cells in healthy lean and CRC subjects inversely 
correlated with the content of two key anti-inflammatory ω3 
PUFA, docosahexaenoic (DHA) and eicosapentaenoic acid (EPA) 
(Figures 6C,D). These results suggest that PUFA composition may 
represent one of the factors that influence VAT microenvironment.
DiscUssiOn
In this study, we performed a comparative analysis of circulating 
versus VAT-associated immune cell subsets unraveling not only a 
different distribution of specific subpopulations in PB versus VAT 
but also alterations in one or in another compartment that are 
associated with obesity or CRC condition. Specifically we observed 
that the frequency of circulating aTreg cell subset is reduced in Ob 
individuals, irrespective of CRC, and inversely correlates with 
FigUre 4 | The frequency of visceral adipose tissue (VAT)-associated 
NKT cells, but not NK cells, is increased in colorectal cancer (CRC)-affected 
subjects as compared to cancer-free donors. VAT stromal vascular fraction 
(SVF) and peripheral blood (PB) lymphocytes isolated from lean normal 
weight (Nw), obese (Ob), lean affected by CRC (Nw/CC), and Ob affected by 
CRC (Ob/CC) donors were analyzed by flow cytometry. Frequencies of NKT 
(CD3+CD56+) (a) and NK (CD3−CD56+) (B) cells were evaluated in the four 
categories of donors. Each dot represents an individual donor. Mean ± SEM 
is shown for each group. *p < 0.05, by analysis of variance.
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BMI, likely reflecting the inflammatory status. In this respect, a 
previous study reported that circulating CD4+CD25+FOXP3+ Treg 
cells are reduced in Ob individuals and their frequency inversely 
correlates with biomarkers of inflammation, weight, BMI, and 
leptin levels (34). We did not observe a significant reduction in 
total Treg cell frequency. However, a deeper characterization of 
Treg cell subsets revealed, for the first time, a selective reduction 
of circulating aTreg cells in obesity. In addition, this is the first 
study in which a comparative analysis between circulating and 
VAT-associated Treg cells has been carried out in lean and Ob 
individuals. We found that Treg cells accumulate in VAT of Ob, but 
not lean, subjects and this was likely due to a protective response 
to the inflammatory status typical of Ob subjects. In keeping 
with this hypothesis, we found a positive correlation between the 
extent of adiposity defined by BMI and the frequency of a VAT-
associated Treg cell population, highly expressing OX40 (OX40+ 
Treg), a marker associated with Treg cell survival and suppressive 
function (28). Therefore, apparently, the VAT microenvironment 
characterizing obesity reproduces a condition that is favorable to 
Treg cell accumulation, in particular of the OX40+ subset, prob-
ably as a result of the need to counteract tissue inflammation. 
Contrasting results have been obtained in mouse and human 
models concerning the role of Treg cells in regulating the inflam-
matory status of AT. While a clear-cut decrease of Treg cells was 
detected in the VAT of Ob mice (35–37), inversely correlating 
with macrophage infiltration (36), a rather different situation 
was observed in humans. In keeping with our results, Zeyda and 
coworkers reported that systemic and AT inflammation posi-
tively correlate with Treg cell abundance within the Ob group, as 
assessed by FOXP3 transcript expression (38). Likewise, Pereira 
and colleagues found a greater FOXP3 mRNA expression in VAT 
of Ob individuals that positively correlated with IL-6 and TNFα 
expression as well as BMI (39). In our study, a deeper phenotypic 
characterization of VAT-associated Treg cells has been performed, 
highlighting, for the first time, the role of OX40 in driving their 
enrichment in VAT.
In this regard, we have previously demonstrated that OX40+ 
Treg cells, expanded in cirrhotic liver, hepatocellular carcinoma, 
and CRC, exhibit a phenotype (Helioshi, CD39hi) compatible with 
a strong suppressive activity, a high proliferative potential and a 
stable regulatory program, suggesting that CRC may take advan-
tage from creating a favorable milieu for their accumulation (29). 
In this study, the lack of accumulation of Treg cells in VAT of CRC-
affected Ob subjects might result from their recruitment at the 
tumor site, an advantageous event facilitating tumor progression. 
Unfortunately, matched tumor tissues were not available at the 
time of analysis to conclusively ascertain the frequency and phe-
notype of Treg cells at the tumor site. The role of VAT-associated 
Treg cells in CRC has been only poorly investigated. Conversely, 
a number of studies have reported increased blood and tumor 
tissue infiltrating Treg cell numbers in CRC patients (40). In par-
ticular, an increase in aTreg cell number has been associated with 
advanced/metastatic tumor stage (41). Our failure in detecting 
circulating aTreg cell increase in CRC-affected subjects might 
be explained by the fact that they have been analyzed at earlier 
stages of disease. Collectively, our results delineate a network of 
diverse Treg cell subsets, differently located in blood and VAT, that 
contribute to obesity-associated immune dysfunctions.
NKT cells have been shown to play beneficial or harmful roles 
in obesity-associated inflammation and co-morbidities (20), as 
well as in CRC development/progression (21, 22). Accumulation 
of total CD3+CD56+ NKT-like cells has been reported in human 
VAT with a decrease of the invariant NKT cell subset associated 
with severe obesity and CRC (42). In keeping with this study, we 
found a selective enrichment of CD3+CD56+ NKT-like cells in 
VAT as compared to blood in healthy individuals and reported 
new evidence for their preferential accumulation in VAT of CRC 
patients, independent of BMI. Conversely, no major changes 
were observed in the periphery. Interestingly, we observed an 
opposite distribution of Treg and NKT-like cells, both endowed 
with immunoregulatory/suppressor activity, in VAT from Ob 
and CRC subjects. Accordingly, when all categories of subjects 
were analyzed, the frequency of NKT-like cells inversely corre-
lated with that of Treg cells. In this regard, a reciprocal regulation 
FigUre 5 | Obese (Ob) and colorectal cancer (CRC)-affected individuals exhibit normal frequencies of peripheral blood (PB) and visceral adipose tissue (VAT)-
associated total γδ T lymphocytes but a significantly reduced Vγ9Vδ2/γδ T cell ratio in PB that correlates with body mass index (BMI). VAT stromal vascular fraction 
(SVF) and PB lymphocytes isolated from lean normal weight (Nw), Ob, lean affected by CRC (Nw/CC), and Ob affected by CRC (Ob/CC) donors were analyzed by 
flow cytometry. Frequency of total γδ T cells (among CD3+ T cells) was evaluated in SVF (a) and PB (B). (c) Vγ9Vδ2/γδ T cell ratios (PB) were calculated in the four 
categories of donors. Each dot represents an individual donor. Mean ± SEM is shown for each group. ***p < 0.001, by analysis of variance. (D) Pearson’s 
correlation (r) between the Vγ9Vδ2/γδ T cell ratio and BMI in Nw and Ob subjects (**p < 0.01).
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between these two immune cell populations has been reported 
in other experimental settings (32, 33), suggesting two different 
scenarios: (i) a bidirectional regulation of their frequency or (ii) 
redundant function but different localization depending on the 
pathophysiological condition. Overall, we could envisage the fol-
lowing scenario at the level of VAT: obesity results in enrichment 
of Treg cells as a mechanism to attenuate excessive inflammation. 
However, their presence could generate an immunosuppressive 
environment favoring tumor establishment. Vice versa, once the 
tumor has established, NKT-like cells might be recruited to the 
VAT. In this regard, the frequency of NKT-like cells at the tumor 
site has been positively correlated with significantly longer overall 
and disease-free survival rates, although the effector mechanisms 
were not identified (43).
In addition to alterations selectively associated with obesity or 
CRC, we demonstrate that specific innate cell subsets are affected 
in both pathologies. We provide herein the first evidence for a 
reduced Vγ9Vδ2/γδ T cell ratio in the PB of CRC-affected indi-
viduals. Moreover, such a reduction was detected in Ob subjects 
with respect to lean individuals, as recently reported (44) and 
the Vγ9Vδ2/γδ T cell ratio was found to inversely correlate with 
BMI. Owing to the protective role of Vγ9Vδ2 T  cell-mediated 
responses in tumor surveillance, obesity- and CRC-induced 
reduction in this cell subset might be detrimental for the control 
of tumor development and growth. Interestingly, due to their 
capacity to specifically recognize and kill CRC initiating cells, γδ 
T lymphocytes have been proposed as a promising tool for novel 
immunotherapeutic strategies in patients with CRC (45). As 
obesity represents a risk factor for CRC and both inflammatory 
conditions are characterized by loss of Vγ9Vδ2 cells, we speculate 
that the impairment of this subset in obesity might contribute to 
CRC immune escape and development.
We have previously demonstrated that specific inflammatory 
signatures characterize the VAT of Ob and CRC subjects (10). 
In particular, a reduced ω3/ω6 PUFA ratio and alterations of 
individual ω6 PUFA profile have been observed in these subjects 
(10, 11). Among the different factors potentially influencing VAT 
microenvironment and immune cell distribution, the relative 
ω3/ω6 PUFA composition, which reflects their dietary intake, 
might play a pivotal role by virtue of the capacity of these molecules 
to exert anti- or pro-inflammatory activities, respectively, and to 
influence immune cell functions (46, 47). We demonstrate herein 
that the relative abundance/distribution of Treg and NKT  cells 
in VAT from Ob and CRC-affected subjects correlates with the 
expression of the ω6 PUFA AA and the ω3 PUFA DHA and EPA.
These results add further evidence for the presence of a 
regulatory/suppressive VAT microenvironment in obesity and 
CRC, highlighted by our previous demonstration of an increased 
IL-10 production, reduced immune-stimulatory properties of 
DC, and impaired generation of γδ T  cell-mediated responses 
induced ex vivo by adipocyte microenvironment (11). In this 
context, the composition of VAT, in particular in FA that reflects 
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FigUre 6 | Inverse distribution between total visceral adipose tissue (VAT) stromal vascular fraction (SVF) regulatory T (Treg) and NKT-like cells and correlation with 
VAT polyunsaturated fatty acid content. Pearson’s correlation between: total Treg and NKT-like cell frequencies in VAT SVF (a), arachidonic acid (AA) content, 
evaluated in visceral adipocytes, and Treg cell frequency estimated in VAT SVF isolated from lean normal weight (Nw) and obese (Ob) donors (B), and 
docosahexaenoic (DHA) (c) and eicosapentaenoic acid (EPA) (D) content, evaluated in visceral adipocytes, and NKT cell frequency estimated in VAT SVF isolated 
from lean (Nw), lean affected by colorectal cancer (CRC) (Nw/CC) and Ob affected by CRC (Ob/CC) donors.
their dietary intake, may represent an important determinant in 
shaping the immune cell phenotype and in influencing processes/
events occurring in distal tissues that may set the basis for tumor 
establishment. A deep characterization of the local and systemic 
immune profile, allowing to distinguish between the subsets 
that drive pro-tumorigenic inflammation or control it, is a key 
issue for the comprehension of the mechanisms involved in the 
establishment of a tumor-favorable environment in obesity, and 
for the definition of more effective cancer prevention strategies 
based on dietary interventions.
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